We are live on
!
Find out more
AA
ALPS Advisors Portfolio holdings
AUM
$21.3B
1-Year Est. Return
21.71%
This Fund
S&P 500
This Quarter
Est. Return
+0.76%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$13.6B
AUM Growth
+$1.31B
(+11%)
Cap. Flow
+$1.24B
Cap. Flow
% of AUM
9.18%
Top 10 Holdings %
Top 10 Hldgs %
52.17%
Holding
753
New
79
Increased
425
Reduced
211
Closed
38
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ETP
Energy Transfer Partners L.p.
ETP
|
+$190M |
| 2 |
Enterprise Products Partners
EPD
|
+$96.4M |
| 3 |
MMP
Magellan Midstream Partners, L.P.
MMP
|
+$94.8M |
| 4 |
Plains All American Pipeline
PAA
|
+$81.9M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$76.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nucor
NUE
|
+$36.6M |
| 2 |
NOV
NOV
|
+$34.2M |
| 3 |
Qualcomm
QCOM
|
+$34.1M |
| 4 |
CenterPoint Energy
CNP
|
+$32.7M |
| 5 |
ConocoPhillips
COP
|
+$31.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 67.49% |
| 2 | Financials | 2.86% |
| 3 | Materials | 2.35% |
| 4 | Healthcare | 2.33% |
| 5 | Industrials | 1.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MBT
651
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
| $348K | ﹤0.01% |
38,152
-2,541
| -6% | -$20.4K |
|
652
MarketAxess Holdings
MKTX
$4.15B
| $347K | ﹤0.01% |
2,364
-77
| -3% | -$12.2K |
|
653
Infosys
INFY
$45B
| $346K | ﹤0.01% |
46,720
+5,306
| +13% | +$39.8K |
|
654
Ambarella
AMBA
$2.99B
| $344K | ﹤0.01% |
6,346
+60
| +1% | +$3.62K |
|
655
Celldex Therapeutics
CLDX
$2.77B
| $344K | ﹤0.01% |
6,487
-2,058
| -24% | -$117K |
|
|
CCXI
656
DELISTED
ChemoCentryx, Inc.
CCXI
| $340K | ﹤0.01% |
+45,942
| New | +$331K |
|
|
GSV
657
DELISTED
Gold Standard Ventures Corp.
GSV
| $340K | ﹤0.01% |
+160,425
| New | +$368K |
|
658
Astronics
ATRO
$3.45B
| $339K | ﹤0.01% |
13,833
-1,924
| -12% | -$50.8K |
|
659
Edwards Lifesciences
EW
$47.6B
| $333K | ﹤0.01% |
10,671
-195
| -2% | -$6.32K |
|
660
Dr. Reddy's Laboratories
RDY
$9.82B
| $333K | ﹤0.01% |
36,805
+1,320
| +4% | +$12.3K |
|
661
LGI Homes
LGIH
$1.4B
| $331K | ﹤0.01% |
11,519
+109
| +1% | +$3.43K |
|
662
Smith & Wesson
SWBI
$655M
| $330K | ﹤0.01% |
20,350
+192
| +1% | +$3.54K |
|
|
BFX
663
DELISTED
BowFlex Inc.
BFX
| $321K | ﹤0.01% |
17,351
+164
| +1% | +$3.05K |
|
664
Ternium
TX
$9.29B
| $320K | ﹤0.01% |
+13,250
| New | +$309K |
|
|
CERN
665
DELISTED
Cerner Corp
CERN
| $320K | ﹤0.01% |
6,745
+64
| +1% | +$3.4K |
|
666
First American
FAF
$7.67B
| $319K | ﹤0.01% |
+8,717
| New | +$334K |
|
667
Honeywell
HON
$77.1B
| $312K | ﹤0.01% |
2,979
+947
| +47% | +$96.3K |
|
668
VeriSign
VRSN
$25.3B
| $310K | ﹤0.01% |
+4,079
| New | +$322K |
|
|
UN
669
DELISTED
Unilever NV New York Registry Shares
UN
| $307K | ﹤0.01% |
+7,471
| New | +$309K |
|
670
Illumina
ILMN
$29.4B
| $302K | ﹤0.01% |
2,421
-79
| -3% | -$10.6K |
|
|
SYNT
671
DELISTED
Syntel Inc
SYNT
| $294K | ﹤0.01% |
14,834
+5,325
| +56% | +$115K |
|
|
TAHO
672
DELISTED
Tahoe Resources Inc
TAHO
| $291K | ﹤0.01% |
30,927
+293
| +1% | +$3.05K |
|
673
C.H. Robinson
CHRW
$22B
| $290K | ﹤0.01% |
+3,955
| New | +$286K |
|
|
INSY
674
DELISTED
Insys Therapeutics, Inc.
INSY
| $281K | ﹤0.01% |
30,564
+289
| +1% | +$3.27K |
|
|
XL
675
DELISTED
XL Group Ltd.
XL
| $278K | ﹤0.01% |
+7,471
| New | +$268K |
|
Similar funds
PAG
MMH
IC
DSA
VARA
SC
CB
ALPS Advisors's Q4 2016 Portfolio in Review
As of Q4 2016, ALPS Advisors held 753 positions worth $13.6B, up 11% from $12.3B the previous quarter. Its ten largest holdings account for 52% of the portfolio.
ALPS Advisors deployed $1.24B of net new capital in Q4 2016, opening 79 new positions and adding to 425 existing holdings. Its largest new stake was Eli Lilly: 558,209 shares worth $41.1M.
By sector, the portfolio is most concentrated in Energy at 67% of assets, up from 66% a quarter earlier, followed by Financials and Materials.
On the sell side, the largest reduction was Nucor, an estimated $36.6M trimmed.
- ALPS Advisors's largest Q4 2016 buy was Eli Lilly: 558,209 shares worth $41.1M.
- ALPS Advisors added most to Energy Transfer Partners L.p. in Q4 2016, an estimated $190M increase.
- ALPS Advisors's biggest Q4 2016 reduction was Nucor, cutting an estimated $36.6M.
- ALPS Advisors fully exited NOV in Q4 2016, selling an estimated $34.2M.
- ALPS Advisors's ten largest holdings make up 52% of its $13.6B portfolio in Q4 2016.
- ALPS Advisors opened 79 new positions and closed 38 in Q4 2016.
- ALPS Advisors's portfolio value rose 11% quarter-over-quarter to $13.6B.
Based on ALPS Advisors's 13F filing for Q4 2016, filed 24 Jan 2017.